100 Albert Road
Level 4 South Melbourne
Melbourne, VIC 3205
Australia
61 3 9087 1598
https://lumosdiagnostics.com
Secteur(s): Healthcare
Secteur d’activité: Diagnostics & Research
Employés à temps plein:
Nom | Titre | Payer | Exercé | Année de naissance |
---|---|---|---|---|
Mr. Samuel Lanyon | Executive Chairman | 165,98k | S.O. | S.O. |
Mr. Douglas Ward | CEO, MD & Director | 905,82k | S.O. | S.O. |
Mr. Barrie Lambert | Chief Financial Officer | 553,58k | S.O. | S.O. |
Dr. Sacha Dopheide Ph.D. | Chief Technology Officer | S.O. | S.O. | S.O. |
Ms. Jennifer Christiansen | Vice President of Corporate Marketing & Communications | S.O. | S.O. | S.O. |
Ms. Sarah Glubka | Senior Director of Human Resources | S.O. | S.O. | S.O. |
Mr. Paul Kase | Senior Vice President of Commercial Operations | S.O. | S.O. | S.O. |
Ms. Tracy Weimar BA, MBA | Company Secretary | S.O. | S.O. | S.O. |
Lumos Diagnostics Holdings Limited, a contract research and development company, develops, manufactures, and commercializes rapid point-of-care (POC) diagnostic products for diagnosis and management of infectious diseases in the United States and Australia. The company's products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop readers, disposable readers, and Lumos Leelu readers. Lumos Diagnostics Holdings Limited was founded in 2004 and is based in Melbourne, Australia.
L’ISS Governance QualityScore de Lumos Diagnostics Holdings Limited en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..